Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Isotretinoin at low doses effectively treats facial papules in frontal fibrosing alopecia.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

Androgenetic alopecia in women needs more research and better management strategies.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

DHEA reduction may be linked to frontal fibrosing alopecia, but more research is needed.

Early and accurate diagnosis of posterior scalp hair loss is crucial for effective treatment and better outcomes.

A woman with hair loss condition experienced rare hair color return, suggesting it might help diagnose the condition.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Koreans have a lower rate of androgenetic alopecia than Caucasians, with men experiencing later baldness.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

FFA in young women is often missed, and no single treatment works best.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

Two women with darker skin had both frontal hair thinning and skin discoloration.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.